Common in aesthetics
Many everyday aesthetic uses of neuromodulators, fillers and PRP involve areas or indications beyond the label. Using hyaluronidase to dissolve filler is another example.
What responsible practice looks like
- The prescriber has a rational, evidence-based reason.
- The patient is told, in the consent, that the use is off-label.
- The protocol and orders describe the use clearly.
- Marketing does not claim FDA approval for an unapproved use.
Marketing is different from practice
Manufacturers may not promote off-label uses, and providers should avoid language implying a product is FDA-approved for something it is not. Describe what you do accurately, and keep claims modest.
Why off-label use is not automatically a problem
Off-label use is common and legal when a prescriber has a clinical rationale. It carries the responsibilities of good practice: the rationale, the evidence, the informed consent and the documentation should all support it.
Common mistakes
- Describing an off-label use to patients as if it were approved.
- Skipping consent that covers the off-label nature.
- No documented rationale.
Frequently asked
Is off-label use legal?
Yes. Prescribers may use marketed products off-label in the practice of medicine. The expectation is that the use is reasoned, disclosed and documented.
Does off-label mean unsafe?
Not necessarily, but evidence varies. Off-label uses may have less safety data than labeled ones, which is why consent and clinical judgment matter.
Educational information only, not legal or clinical advice. Rules and Board positions change, so confirm current requirements with the relevant Arizona licensing board and an Arizona healthcare attorney.